The Renal Center

Filter Your Results

 

News

 

Boston Scientific Begins Novel REDUCE-HTN: REINFORCE Study of Vessix Renal Denervation System

April 16, 2015 -- Boston Scientific Corporation announced the initiation of the REDUCE-HTN: REINFORCE study, which is taking a new approach to evaluate the performan…

Alternative Interpretation of ASTRAL and CORAL Suggests a Role for Renal Artery Intervention

April 8, 2015 -- In the European Journal of Vascular and Endovascular Surgery (EJVES), Irwin V. Mohan, MD, et al published an assessment of the literature on intervention…

Medtronic Announces SPYRAL HTN Global Clinical Trial Program for Renal Denervation

April 1, 2015 -- Medtronic plc announced the initiation of the SPYRAL HTN global clinical trial program to study renal denervation in patients with uncontrolled hypertension. …

Study Evaluates Renal Artery Aneurysm Management

April 1, 2015 -- A study of the contemporary management of renal artery aneurysms (RAAs) was published by Jill Q. Klausner, BS, et al in the Journal of Vascular Surgery (…

Vascular Solutions Launches PolarCath Peripheral Dilatation System in United States

March 16, 2015 -- Vascular Solutions, Inc. announced that it has commenced sales of the PolarCath peripheral dilatation system in the United States in collaboration with the p…

ISET Panel Considers Future of Renal Denervation to Treat Hypertension

February 2, 2015 -- A panel at ISET 2015: the International Symposium on Endovascular Therapy in Hollywood, Florida, discussed the past and future investigations of renal dene…

Dr. Lawson to Present ISET Lecture on Humacyte’s Bioengineered Blood Vessel Replacement

January 26, 2015 -- Humacyte, Inc., announced that Jeffrey H. Lawson, MD, who serves as a clinical consultant for the company, is a keynote speaker at ISET 2015: the 27th Inte…

FDA Clears ZigiWire Access Guidewire System

December 19, 2014 -- Vascular Solutions, Inc. announced that the ZigiWire access support guidewire system has received 510(k) clearance from the US Food and Drug Administratio…

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.